The NMPA acceptance of Chance Pharma’s first new drug application advances CXG87, an improved budesonide/formoterol dry powder inhalation therapy, toward potential commercialisation in China. ...
Jointly developed by SGH, SingHealth and MOHT, LEA-Net uses patient data to identify individuals at higher risk of lower extremity amputation three to five years before foot ulcers and infections develop. ...
Expansion of Vanquish procedures highlights growing adoption of minimally invasive water vapour ablation technology for prostate disease ...
Together, these announcements represent a step forward in increasing accessibility to complex DNA...
Funding to accelerate development of real-time imaging solutions aimed at improving surgical precision and patient outcomes...
Calidar completes enrollment in a first-in-human study of its 4D Mammography system, advancing a next-generation imaging platform designed to enhance breast cancer detection through molecular-level diagnostics....
Deployment of compact point-of-care brain PET scanners reflects growing demand for earlier, accessible neurodiagnostics in community settings...
The respiratory system has evolved efficient mechanisms to clear inhaled particles...
The company is seeking to overcome long-standing limitations of conventional HIFU systems and expand the role of non-invasive therapies in clinical practice...
Regulatory milestone expands potential use of anti-CD20 therapy in lupus, building on prior success in lupus nephritis...
